-
Signature
-
/s/ Vijay Iyer, Attorney-in-Fact
-
Issuer symbol
-
BKNG
-
Transactions as of
-
15 Oct 2025
-
Net transactions value
-
-$3,213,454
-
Form type
-
4
-
Filing time
-
16 Oct 2025, 16:30:12 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Fogel Glenn D |
CEO AND PRESIDENT, Director |
BOOKING HOLDINGS INC., 800 CONNECTICUT AVENUE, NORWALK |
/s/ Vijay Iyer, Attorney-in-Fact |
16 Oct 2025 |
0001516908 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BKNG |
Common Stock |
Sale |
$81,071 |
-16 |
-0.07% |
$5066.94 |
23,591 |
15 Oct 2025 |
Direct |
F1, F2 |
| transaction |
BKNG |
Common Stock |
Sale |
$5,068 |
-1 |
-0% |
$5068.25 |
23,590 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$5,070 |
-1 |
-0% |
$5070.38 |
23,589 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$218,346 |
-43 |
-0.18% |
$5077.82 |
23,546 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$35,557 |
-7 |
-0.03% |
$5079.58 |
23,539 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,489 |
-6 |
-0.03% |
$5081.46 |
23,533 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$219,309 |
-43 |
-0.18% |
$5100.22 |
23,490 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,619 |
-6 |
-0.03% |
$5103.09 |
23,484 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,627 |
-6 |
-0.03% |
$5104.43 |
23,478 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$220,177 |
-43 |
-0.18% |
$5120.39 |
23,435 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,758 |
-6 |
-0.03% |
$5126.32 |
23,429 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$220,512 |
-43 |
-0.18% |
$5128.19 |
23,386 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,786 |
-6 |
-0.03% |
$5130.93 |
23,380 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$246,863 |
-48 |
-0.21% |
$5142.97 |
23,332 |
15 Oct 2025 |
Direct |
F1, F3 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,872 |
-6 |
-0.03% |
$5145.34 |
23,326 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$221,479 |
-43 |
-0.18% |
$5150.68 |
23,283 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$283,397 |
-55 |
-0.24% |
$5152.68 |
23,228 |
15 Oct 2025 |
Direct |
F1, F4 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,944 |
-6 |
-0.03% |
$5157.27 |
23,222 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$257,974 |
-50 |
-0.22% |
$5159.47 |
23,172 |
15 Oct 2025 |
Direct |
F1, F5 |
| transaction |
BKNG |
Common Stock |
Sale |
$30,966 |
-6 |
-0.03% |
$5160.98 |
23,166 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$252,967 |
-49 |
-0.21% |
$5162.59 |
23,117 |
15 Oct 2025 |
Direct |
F1, F6 |
| transaction |
BKNG |
Common Stock |
Sale |
$222,114 |
-43 |
-0.19% |
$5165.44 |
23,074 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$222,204 |
-43 |
-0.19% |
$5167.53 |
23,031 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$31,181 |
-6 |
-0.03% |
$5196.86 |
23,025 |
15 Oct 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
$224,105 |
-43 |
-0.19% |
$5211.74 |
22,982 |
15 Oct 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: